Cardiovascular Health

The Pharmacy Times® Cardiovascular Health Resource Center is a comprehensive resource for clinical news and expert insights on the health of the heart and blood vessels, including coronary heart disease, stroke, heart failure, heart arrhythmias, and heart valve issues.

Latest News

SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure
SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure

April 15th 2024

SGLT-2 inhibitors reduce cardiovascular deaths, heart failure hospitalizations, hyperkalemia, and decline of renal function in patients with HFrEF.

3d illustration of human heart and cardiogram on futuristic blue background. | Image Credit: Artem - stock.adobe.com
Real-World Data on Mavacamten Builds on Clinical, Safety Profile

April 15th 2024

Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure
Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure

April 8th 2024

human heart and cardiogram on futuristic blue background | Image Credit: Artem - stock.adobe.com
New Data Shows Positive Results for Sotagliflozin for Patients With Chronic Kidney Disease, Diabetes

April 7th 2024

Study: Empagliflozin Reduces MACE Regardless of Baseline Albuminuria Levels
Study: Empagliflozin Reduces MACE Regardless of Baseline Albuminuria Levels

April 7th 2024

Latest CME Events & Activities

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

0.75 Credit / Cardiology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Introduction to Anticoagulation and the Appropriate Patient

1.0 Credit / Cardiology

View More

The Treatment Landscape and a Review of Approved DOAC Agents

1.0 Credit / Cardiology

View More

Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management

1.0 Credit / Cardiology

View More

Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction

1.0 Credit / Cardiology

View More

Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

Understanding the Challenges of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings

1.0 Credit / Cardiology

View More

Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fraction

1.0 Credit / Cardiology

View More

Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and Improving Adherence

1.0 Credit / Cardiology

View More

Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration

1.0 Credit / Cardiology

View More

Iron Deficiency and Anemia in Heart Failure: Clinical Applications for the Use of Intravenous Iron

1.5 Credits / Cardiology

View More

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

More News

© 2024 MJH Life Sciences

All rights reserved.